VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
PRMEPrime Medicine, Inc.
$3.23$583M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksPRMEPrice History

PRME logoPrime Medicine, Inc. (PRME) Stock Price History

Historical prices from 2022 to 2026

$3.23+0.07  (+2.22%)close Jun 18
Returns
1M
+14.9%
3M
-8.5%
YTD
-8.5%
1Y
+79.4%
3Y
-40.3%
5Y
-26.8%
ATH$21.73Nov 2022-85.1%
ATL$1.11May 2025pre-split
Avg Vol (50D)2.5M/ day
52-Week Range$2.02 — $6.94
LowCurrent: $3.23High

Loading 10-year price history...

PRME Historical Performance

1 YearTotal Return
+79.4%
Price: +79.4%
3 YearsTotal Return
-78.8%
CAGR: -40.3%
Price: -78.7%
5 YearsTotal Return
-79.0%
CAGR: -26.8%
Price: -79.0%
YTD
-8.5%

PRME Annual Returns

Year-by-year price performance · 2022–2026

Best+20.9%2022
Worst-66.7%2024
Up years3/5
2022+20.9%
2023-49.5%
2024-66.7%
2025+16.1%
2026+30.9%
2022 annual price return
+20.9%
2023 annual price return
-49.5%
2024 annual price return
-66.7%
2025 annual price return
+16.1%
2026 annual price return
+30.9%
LessMore
Alpha vs S&P 500
1Y+54.5%
3Y-60.3%
5Y-39.6%

Price returns only.

Download Historical Data

919 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

PRME Stock Price Trajectory (2022–2026)

As of June 22, 2026, Prime Medicine, Inc. (PRME) trades at $3.23, representing a +79.4% return over the past year. The stock has delivered a -79.0% total return over five years (-26.8% CAGR), reflecting challenging market conditions.

The stock reached its all-time high of $21.73 on November 14, 2022. From this peak, PRME has corrected -85.1%, currently trading 18% below its 200-day moving average, suggesting potential weakness.

When compared to Healthcare sector peers BEAM (+100.9% 1Y), CRSP (+21.7% 1Y), and EDIT (+14.5% 1Y), PRME has underperformed the peer group average. Compare PRME vs BEAM →

PRME Historical Price Data · from 2022

Rows 1–50 of 919
Date Open High Low Close Volume Change %
2026-06-183.273.373.103.233.19M+2.22%
2026-06-172.913.272.873.164.18M+10.10%
2026-06-162.902.982.812.872.14M-1.03%
2026-06-152.903.062.842.902.70M+4.50%
2026-06-122.822.862.762.771.70M-1.60%
2026-06-112.712.872.672.822.48M+4.06%
2026-06-102.862.962.712.712.50M-5.90%
2026-06-092.993.052.792.882.32M-2.70%
2026-06-083.133.152.922.962.46M-3.27%
2026-06-053.423.442.943.064.46M-11.82%
2026-06-043.173.613.173.473.83M+10.51%
2026-06-033.273.273.083.143.36M-2.18%
2026-06-023.373.373.063.213.30M-5.59%
2026-06-013.543.543.283.402.47M-4.23%
2026-05-293.383.563.263.553.26M+4.41%
2026-05-283.233.433.123.402.22M+3.03%
2026-05-272.983.452.983.304.61M+11.11%
2026-05-263.013.052.892.972.32M0.00%
2026-05-222.953.102.952.972.21M+0.68%
2026-05-212.812.972.752.951.98M+4.24%
2026-05-202.702.872.702.832.15M+4.81%
2026-05-192.782.812.682.702.17M-3.91%
2026-05-182.942.982.752.813.62M-4.10%
2026-05-153.083.092.932.933.09M-6.39%
2026-05-143.303.343.113.132.21M-4.28%
2026-05-133.263.353.233.272.31M-1.06%
2026-05-123.253.353.193.313.05M+2.01%
2026-05-113.283.603.193.243.19M+0.93%
2026-05-083.213.403.083.212.44M+3.05%
2026-05-073.413.553.063.123.94M-8.65%
2026-05-063.463.483.283.412.69M+0.59%
2026-05-053.493.553.283.392.65M-2.02%
2026-05-043.403.583.373.461.10M+1.47%
2026-05-013.523.533.353.411.78M-3.81%
2026-04-303.543.693.503.541.55M+0.42%
2026-04-293.633.693.513.531.41M-4.34%
2026-04-283.643.793.623.691.57M+0.54%
2026-04-273.733.983.643.671.48M-0.81%
2026-04-243.823.853.663.701.45M-3.65%
2026-04-233.974.033.783.841.84M-3.03%
2026-04-223.823.973.813.961.76M+3.94%
2026-04-213.893.963.753.812.11M-2.06%
2026-04-203.773.923.693.891.04M+2.10%
2026-04-173.783.913.763.811.88M+3.81%
2026-04-163.793.793.613.671.51M-3.17%
2026-04-153.763.843.653.792.17M+2.43%
2026-04-143.763.873.653.702.44M+1.09%
2026-04-133.383.733.363.661.80M+6.71%
2026-04-103.503.543.273.431.68M-2.28%
2026-04-093.503.553.453.511.27M-0.85%
…
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

PRME — Frequently Asked Questions

Quick answers to the most common questions about buying PRME stock.

How has PRME stock performed recently?

PRME returned +79.4% over the past year, beating its 5-year annualized CAGR of -26.8%. The stock trades below its 200-day moving average, confirming the uptrend.

What is PRME's all-time high price?

Prime Medicine, Inc. reached $21.73 on 2022-11-14. The 52-week high is $6.94. Current 1-year return of +79.4% places the stock closer to historical peaks.

Where can I download PRME historical price data?

This page provides PRME daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2022-2026, downloadable in CSV format.

460 data points · sampled from 919